# Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

> **NCT04798651** · NA · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 150 (estimated)

## Conditions studied

- Multiple Sclerosis
- Clinically Isolated Syndrome

## Interventions

- **BIOLOGICAL:** blood sample
- **BIOLOGICAL:** cerebro-spinal fluid

## Key facts

- **NCT ID:** NCT04798651
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-30
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04798651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04798651, "Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04798651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*